Rawal, N., and Pangburn, M.K.: Structure/function of C5 convertases of complement. Int. Immunopharmacol. 2001, 1:415–422.
2-13 Ingestion of complement-tagged pathogens by phagocytes is mediated by receptors for the bound complement proteins.
Gasque, P.: Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 2004, 41:1089–1098.
Helmy, K.Y., Katschke, K.J., Jr., Gorgani, N.N., Kljavin, N.M., Elliott, J.M., Diehl, L., Scales, S.J., Ghilardi, N., and van Lookeren Campagne, M.: CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006, 124:915–927.
2-14 The small fragments of some complement proteins initiate a local inflammatory response.
Barnum, S.R.: C4a: an anaphylatoxin in name only. J. Innate Immun. 2015, 7:333-9.
Kohl, J.: Anaphylatoxins and infectious and noninfectious inflammatory diseases. Mol. Immunol. 2001, 38:175–187.
Schraufstatter, I.U., Trieu, K., Sikora, L., Sriramarao, P., and DiScipio, R.: Complement C3a and C5a induce different signal transduction cascades in endothelial cells. J. Immunol. 2002, 169:2102–2110.
2-15 The terminal complement proteins polymerize to form pores in membranes that can kill certain pathogens.
Hadders, M.A., Beringer, D.X., and Gros, P.: Structure of C8α-MACPF reveals mechanism of membrane attack in complement immune defense. Science 2007, 317:1552–1554.
Parker, C.L., and Sodetz, J.M.: Role of the human C8 subunits in complement-mediated bacterial killing: evidence that C8γ is not essential. Mol. Immunol. 2002, 39:453–458.
Scibek, J.J., Plumb, M.E., and Sodetz, J.M.: Binding of human complement C8 to C9: role of the N-terminal modules in the C8α subunit. Biochemistry 2002, 41:14546–14551.
complement activation and protect the host from their destructive effects.
Ambati, J., Atkinson, J.P., and Gelfand, B.D.: Immunology of age-related macular degeneration. Nat. Rev. Immunol. 2013, 13:438–451.
Atkinson, J.P., and Goodship, T.H.: Complement factor H and the hemolytic uremic syndrome. J. Exp. Med. 2007, 204:1245–1248.
Jiang, H., Wagner, E., Zhang, H., and Frank, M.M.: Complement 1 inhibitor is a regulator of the alternative complement pathway. J. Exp. Med. 2001, 194:1609–1616.
Miwa, T., Zhou, L., Hilliard, B., Molina, H., and Song, W.C.: Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 2002, 99:3707–3716.